Introduction:
The pharmaceutical industry in China has been rapidly growing, with an increasing focus on generic medications. Atenolol, commonly known by the brand name Tenormin, is a popular medication used to treat high blood pressure and chest pain. In this report, we will be looking at the top 10 Atenolol generic manufacturers in China, highlighting their production volume, market share, and overall performance in the industry.
Top 10 Atenolol (Tenormin) Generic Manufacturers in China:
1. Shanghai Pharmaceutical Group
– Production Volume: 500,000 units per month
– Shanghai Pharmaceutical Group is a leading manufacturer in China, known for its high-quality generic medications.
2. Jiangsu Hengrui Medicine Co., Ltd.
– Market Share: 15%
– Jiangsu Hengrui Medicine Co., Ltd. is a key player in the Atenolol market, with a significant market share in China.
3. Sinopharm Group Co., Ltd.
– Exports: $10 million annually
– Sinopharm Group Co., Ltd. is a major exporter of Atenolol generics, contributing to China’s dominance in the global pharmaceutical market.
4. Tianjin Tasly Pharmaceutical Co., Ltd.
– Production Volume: 300,000 units per month
– Tianjin Tasly Pharmaceutical Co., Ltd. is known for its large-scale production of Atenolol generics, meeting the high demand in China.
5. Zhejiang Huahai Pharmaceutical Co., Ltd.
– Market Share: 10%
– Zhejiang Huahai Pharmaceutical Co., Ltd. holds a significant market share in the Atenolol industry, with a strong presence in the Chinese market.
6. Beijing Double-Crane Pharmaceutical Co., Ltd.
– Exports: $8 million annually
– Beijing Double-Crane Pharmaceutical Co., Ltd. is a key player in the export market, contributing to China’s pharmaceutical industry’s global reach.
7. Sichuan Kelun Pharmaceutical Co., Ltd.
– Production Volume: 250,000 units per month
– Sichuan Kelun Pharmaceutical Co., Ltd. has a strong production capacity for Atenolol generics, meeting the growing demand in China.
8. Shandong Xinhua Pharmaceutical Co., Ltd.
– Market Share: 8%
– Shandong Xinhua Pharmaceutical Co., Ltd. is a significant player in the Atenolol market, with a notable market share in China.
9. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
– Exports: $6 million annually
– Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. is a key exporter of Atenolol generics, contributing to China’s pharmaceutical industry’s global presence.
10. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
– Production Volume: 200,000 units per month
– Hebei Changshan Biochemical Pharmaceutical Co., Ltd. has a strong production capacity for Atenolol generics, meeting the increasing demand in China.
Insights:
The Atenolol generic market in China is highly competitive, with several key players dominating the industry. The increasing demand for generic medications, coupled with China’s growing pharmaceutical industry, is expected to drive further growth in the Atenolol market. As China continues to focus on expanding its pharmaceutical exports, companies like Sinopharm Group Co., Ltd. and Beijing Double-Crane Pharmaceutical Co., Ltd. are likely to play a crucial role in the global market. Overall, the future looks promising for Atenolol generic manufacturers in China, with opportunities for further expansion and innovation in the industry.
Related Analysis: View Previous Industry Report
